Lv1
60 积分 2023-11-07 加入
RIPTACs for Precision Cancer Therapy: A Novel Modality with the Inspiration of HLD-0915 as the First Candidate in Clinical Trials
10天前
已完结
Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies
10天前
已完结
Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer Immunotherapy
4个月前
已完结
Cellular quality control by the ubiquitin-proteasome system and autophagy
6个月前
已完结
Harnessing hydrophobic tag technology to combat drug-resistant influenza: design, synthesis and potency of oseltamivir-derived HyTTDs
6个月前
已完结
Small-molecule hydrophobic tagging–induced degradation of HaloTag fusion proteins
6个月前
已完结
Rational Chemical Design of Molecular Glue Degraders
6个月前
已完结
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor
7个月前
已完结
Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer
8个月前
已完结
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
8个月前
已完结
皖公网安备34019202002308
